Document Detail


Conformation-based restrictions and scaffold replacements in the design of hepatitis C virus polymerase inhibitors: discovery of deleobuvir (BI 207127).
MedLine Citation:
PMID:  24159919     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Conformational restrictions of flexible torsion angles were used to guide the identification of new chemotypes of HCV NS5B inhibitors. Sites for rigidification were based on an acquired conformational understanding of compound binding requirements and the roles of substituents in the free and bound states. Chemical bioisosteres of amide bonds were explored to improve cell-based potency. Examples are shown, including the design concept that led to the discovery of the phase III clinical candidate deleobuvir (BI 207127). The structure-based strategies employed have general utility in drug design.
Authors:
Steven R LaPlante; Michael Bös; Christian Brochu; Catherine Chabot; René Coulombe; James R Gillard; Araz Jakalian; Martin Poirier; Jean Rancourt; Timothy Stammers; Bounkham Thavonekham; Pierre L Beaulieu; George Kukolj; Youla S Tsantrizos
Related Documents :
23117589 - Exploring the pde5 h-pocket by ensemble docking and structure-based design and synthesi...
24586769 - Disulfide linkages in plasmodium falciparum plasmepsin-i are essential elements for its...
25076049 - Systematic tuning of heme redox potentials and its effects on o2 reduction rates in a d...
24816099 - Divalent metal ion-based catalytic mechanism of the nudix hydrolase orf153 (ymfb) from ...
11524009 - Steady-state kinetic characterization of substrates and metal-ion specificities of the ...
22995909 - Histone deacetylase inhibitor (hdaci) suberoylanilide hydroxamic acid (saha)-mediated c...
8817679 - Role of insulin-like growth factor binding proteins in the control of igf actions.
9342229 - Type-1 plasminogen-activator inhibitor -- conformational differences between latent, ac...
9540459 - Construction of a model of the candida albicans lanosterol 14-alpha-demethylase active ...
Publication Detail:
Type:  Journal Article     Date:  2013-11-11
Journal Detail:
Title:  Journal of medicinal chemistry     Volume:  57     ISSN:  1520-4804     ISO Abbreviation:  J. Med. Chem.     Publication Date:  2014 Mar 
Date Detail:
Created Date:  2014-03-13     Completed Date:  2014-05-15     Revised Date:  2014-05-21    
Medline Journal Info:
Nlm Unique ID:  9716531     Medline TA:  J Med Chem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1845-54     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antiviral Agents / chemistry,  pharmacology*
Benzimidazoles / chemistry,  pharmacology*
Crystallography, X-Ray
Drug Design*
Enzyme Inhibitors / chemistry,  pharmacology*
Hepacivirus / drug effects*,  enzymology
Indoles / chemistry,  pharmacology*
Magnetic Resonance Spectroscopy
Models, Molecular
Molecular Conformation
Viral Nonstructural Proteins / antagonists & inhibitors*
Chemical
Reg. No./Substance:
0/Antiviral Agents; 0/Benzimidazoles; 0/Enzyme Inhibitors; 0/Indoles; 0/NS-5 protein, hepatitis C virus; 0/Viral Nonstructural Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Increased risk of gastric adenocarcinoma after treatment of primary gastric diffuse large B-cell lym...
Next Document:  Mental Health Consequences of Disasters.